NURS FPX 9030 Assessment 2 Data and Data Analysis

NURS FPX 9030 Assessment 2 Data and Data Analysis

Student Name

Capella University

NURS-FPX9030: Doctor of Nursing Practice Across the Lifespan III

Professor Name

Submission Date

×

    Please enter correct phone number and email address to receive OTP on your phone & email.

    Privacy PolicySMS Terms And Conditions

    Introduction

    Diabetes mellitus is still one of the most common chronic diseases faced by patients during visits to primary care facilities. Over the last year at the project site, several patients did not achieve good control of diabetes, as evidenced by having 42% of patients with an A1c greater than 9% and only 36% of patients having an A1C less than 7 percent (Chief Nursing Officer, Personal Communication, October 10th, 2020). The percentages are much higher in comparison with national standards of diabetes management because they are around 22 percent of adults with diabetes with poor glycemic control and about 50 percent of them with A1C goals (Adjei et al., 2020; Chief Nursing Officer, Personal Communication, October 10th, 2020). The absence of a standardized, protocolized course of follow-up, with the possibility to at least receive education on diabetes, led to patients not receiving adequate education at all, and missing follow-up opportunities and less than optimal outcomes. To fill the gaps, a quality improvement (QI) initiative was carried out based on the following PICOT question: Among nursing personnel working with adult patients with diabetes (P), the introduction of the ADA diabetes follow-up protocol (I) in comparison with the current practice (C) in terms of its effects on glycemic control (O) in 8 weeks (T)? An eight-week project adopted an American Diabetes Association (ADA) diabetes follow-up protocol and assessed the effects of the protocol on the glycemic outcomes, clinical competency of staff, staff adherence to follow-up, and self-management behaviors in patients. The project design, data collection methods, statistical studies, and findings are reflected in the paper, and the evidence to prove that structured, evidence-based ADA follow-up protocols may lead to clinically significant outcomes in glycemic control is provided.

    Project Design and Data Collection

    The pre-post design was utilized by the project team to acquire baseline and post-intervention data of the 20 adult participants and 8 nurses who are enrolled in the project. Before the project started, IRB approval was taken care of, and necessary Health Insurance Portability and Accountability Act (HIPAA) compliance was established; to maintain anonymity, the names of all participants were substituted with coded ones. The pre-post project design is a frequently employed technique within quality improvement tests to analyze the data and accomplishments of well-organized clinical measures. It is based on a pre-post design framework to be an effective measure of the impact of structured intervention on achieving success in real-life healthcare environments (Mitchell et al., 2025). To yield a valid and reliable measure of clinical outcomes, data collection tools adopted in a quality improvement project need to be valid and reliable to generate an accurate measure of clinical outcomes (Kaplan et al., 2021). Discussing all data collection tools, their content validity was verified as strong, considering evaluation by experts and further consistent use of the same procedures to collect data during the project, which lasted eight weeks.

    Data Analysis

    The results obtained at the 8-week follow-up time on the quantitative outcomes were measured using both descriptive statistics to determine the impact of the ADA diabetes follow-up protocol on the glycemic results, the competence of the staff, and the self-management behaviors of the staff. Since there was a need to compare baseline vs. week 8 HbA1c values of the participants, the primary inferential statistics were t-tests to compare the mean differences of one group at two different times. Descriptive statistics (percentage) were produced to sum up the adherence rates to follow up, competency scores of the staff, and the checklist results of self-management. The projects of quality improvement need to be analyzed statistically in order that the team can understand whether the changes in observed outcomes are significant changes in clinical outcomes or mere accidents of chance (Mangory et al., 2021). Moreover, repeated measures (pre and post) can be performed using the same group of participants, which increases the sensitivity of the statistic and sluces individual variability (Chicco et al., 2025). All analyses were performed on de-identified data obtained in the EMR of the clinic and the standardized assessment tools; as a result, all analyses were done in summary tables to be easily interpreted.

    Project Results

    All outcome measures improved among the participants who joined the project compared to the measurements of outcomes at baseline. As an example, the mean HbA1c fell 1.52 percentage points (9.95 per cent to 8.22 per cent) in 8 weeks. The respondents who responded were extremely involved in utilizing the structured protocol given to them, according to the follow-up completion rate of 89.2. Following training, 7 of 8 (87.5%) of the nursing staff scored within the 80 percent competency range, with an average score of 59.0 percent before the training and 85.4 percent after training. The mean self-management engagement scores of those who attended week 8 were 7.4 out of 10, with 70% of those attending the week 8 fully compliant with the medications, 65% of those attending the week 8 regularly completing the daily monitoring of blood sugar levels. On the whole, the findings suggest general positive changes concerning the clinical outcome, operational outcome, and behavioral outcome domains of the participants who participated in the project. Tables 1 to 6 in Appendix A contain the results.

    Project Outcomes

    The project results evidence suggests that the application of the follow-up protocol offered by the American Diabetes Association (ADA) turned out to be effective in reaching meaningful changes in glycemic control, thus addressing the PICOT question. The resultant HbA1c mean decrease of 1.52 points surpassed the set criteria of success of 0.5 points and was clinically significant. Nonetheless, merely 10% of study participants had reached the target HbA1c (<7%); despite significant improvement observed after 8 weeks of intervention, it is likely that the full target would also need a more extended intervention. Participants had 67% of planned visits delivered because of transportation: this led to adverse glycemic patterns; ubiquitous barriers and transportation issues were other unanticipated results. Continuous improvement quality initiatives aimed at chronic disease management always reveal that organized, researched procedures result in measurable improvement (Endalamaw et al., 2024). Continuous tracking, adjustment intervention, and follow-up of at least 1 year of outpatient glycemic measurement patterns are necessary to make sure that the benefit provided by outpatient glycemic improvement programs is sustainable (Jahed et al., 2025). The project strengths were a high level of staff competency, a high level of follow-up adherence, and proper EHR documentation. Limitations were also associated with the short (8-week) length of intervention time; the results might not be applied to other groups of adults with diabetes in wider community-based clinical environments.

    Conclusion

    An 8-week trial on the use of the ADA diabetes follow-up protocol demonstrated that the use of the intervention resulted in substantial clinical outcomes in terms of glycemic control, increase in staff competency, compliance with follow-up, and self-management behaviour in adults with type II diabetes in a nurse-led primary care infrastructure. Even despite the still some limitations observed in the attainment of full glycemic target levels, the participants were only followed over a period of time. The results all indicate that promoting and enforcing standard evidence-based procedures of diabetes follow-up will result in increased success in enhancing the outcome of chronic diseases within the outpatient primary care environment through the application of a continuous process.

    Step By Step Instructions To Write
    NURS FPX 9030 Assessment 2

    ×

      Please enter correct phone number and email address to receive OTP on your phone & email.

      Privacy PolicySMS Terms And Conditions

      Contact us today and receive expert step-by-step instructions for NURS FPX 9030 Assessment 2.

      Instructions File For
      NURS FPX 9030 Assessment 2

      ×

        Please enter correct phone number and email address to receive OTP on your phone & email.

        Privacy PolicySMS Terms And Conditions

        Contact us to get the instruction file.

        Scoring Guide for
        NURS FPX 9030 Assessment 2

        ×

          Please enter correct phone number and email address to receive OTP on your phone & email.

          Privacy PolicySMS Terms And Conditions

          Contact us to get the scoring guide.

          References in APA Format For
          NURS FPX 9030 Assessment 2

          ×

            Please enter correct phone number and email address to receive OTP on your phone & email.

            Privacy PolicySMS Terms And Conditions

            Below are the references used in NURS FPX 9030 Assessment 2 Data and Data Analysis:

            Adjei, S. K., Adjei, P., & Nkrumah, P. A. (2025). Poor glycemic control and its predictors among type 2 diabetes patients: Insights from a single‐center retrospective study in Ghana. Health Science Reports8(3), 8–12. https://doi.org/10.1002/hsr2.70558

            Chicco, D., Sichenze, A., & Jurman, G. (2025). A simple guide to the use of Student’s t-test, Mann-Whitney U test, Chi-squared test, and Kruskal-Wallis test in biostatistics. BioData Mining18(1), e56. https://doi.org/10.1186/s13040-025-00465-6

            Endalamaw, A., Khatri, R. B., Mengistu, T. S., Erku, D., Wolka, E., Zewdie, A., & Assefa, Y. (2024). A scoping review of continuous quality improvement in healthcare system: Conceptualization, models and tools, barriers and facilitators, and impact. BioMed Central Health Services Research24(1), e487. https://doi.org/10.1186/s12913-024-10828-0

            Kaplan, R. S., Jehi, L., Ko, C. Y., Pusic, A., & Witkowski, M. (2021). Health Care Measurements that Improve Patient Outcomes. NEJM Catalyst, 2(2). https://doi.org/10.1056/cat.20.0527

            Mangory, K. Y., Ali, L. Y., Rø, K. I., & Tyssen, R. (2021). Effect of burnout among physicians on observed adverse patient outcomes: a literature review. BMC Health Services Research, 21(1). https://doi.org/10.1186/s12913-021-06371-x

            Mitchell, S., Schmitz, F. M., Janusz Janczukowicz, Buzzi, A.-L., Haas, N., Hitzblech, T., Wagenfuehr, J., Idris Guessous, & Guttormsen, S. (2025). Does Education Design Matter? Evaluating an Evidence-Based Continuing Education Intervention on Genomic Testing for Primary Care; a Pre-Test Post-Test Study. Journal of CME, 14(1). https://doi.org/10.1080/28338073.2025.2526234

            Jahed, S. A., Nikoosokhan, A., Moravej, H., Sarkheil, P., Malek, M., Esteghamati, A., Hosseinpanah, F., & Sedaghat, S. (2025). The use of continuous glucose monitoring in outpatient diabetes care: Iranian expert consensus statement. Diabetes Research and Clinical Practice230, e112961. https://doi.org/10.1016/j.diabres.2025.112961

            Tables Data For
            NURS FPX 9030 Assessment 2

            Table 1

            Demographic Characteristics and Baseline HbA1c (N = 20)

            Participant ID

            Age Group

            Sex

            Race/Ethnicity

            Insurance Type

            T2DM Duration (yrs)

            Baseline HbA1c (%)

            P001

            45–54

            Female

            Hispanic/Latino

            Medicaid

            6

            9.8

            P002

            55–64

            Male

            Black/African American

            Medicare

            11

            10.2

            P003

            35–44

            Female

            White/Non-Hispanic

            Private

            3

            8.7

            P004

            55–64

            Female

            Hispanic/Latino

            Medicaid

            9

            11.1

            P005

            45–54

            Male

            Asian

            Medicaid

            5

            9.4

            P006

            65+

            Male

            Black/African American

            Medicare

            14

            10.8

            P007

            35–44

            Female

            White/Non-Hispanic

            Private

            2

            8.3

            P008

            55–64

            Male

            Hispanic/Latino

            Medicaid

            8

            9.9

            P009

            45–54

            Female

            Asian

            Private

            4

            8.9

            P010

            65+

            Female

            Black/African American

            Medicare

            16

            11.4

            P011

            35–44

            Male

            White/Non-Hispanic

            Private

            3

            8.5

            P012

            55–64

            Female

            Hispanic/Latino

            Medicaid

            10

            10.6

            P013

            45–54

            Male

            Black/African American

            Medicaid

            7

            9.7

            P014

            65+

            Female

            Hispanic/Latino

            Medicare

            13

            10.9

            P015

            35–44

            Male

            Asian

            Private

            2

            8.2

            P016

            55–64

            Female

            White/Non-Hispanic

            Private

            9

            9.3

            P017

            45–54

            Male

            Hispanic/Latino

            Medicaid

            6

            10.1

            P018

            65+

            Female

            Black/African American

            Medicare

            18

            11.7

            P019

            35–44

            Female

            Asian

            Private

            1

            7.8

            P020

            55–64

            Male

            White/Non-Hispanic

            Private

            11

            9.6

            Note. All patient identifiers have been replaced with project codes. Age group, sex, race/ethnicity, and insurance type were self-reported. T2DM duration and baseline HbA1c were extracted from EHR records at Week 1. T2DM = type 2 diabetes mellitus; HbA1c = hemoglobin A1c.

            Table 2

            HbA1c Outcomes Across Measurement Time Points (N = 20)

            Participant ID

            Baseline HbA1c (%)

            Week 4 HbA1c (%)

            Week 8 HbA1c (%)

            Change (Baseline to Wk 8)

            Target Met (<7%)

            P001

            9.8

            9.1

            8.4

            −1.4

            No

            P002

            10.2

            9.6

            8.8

            −1.4

            No

            P003

            8.7

            8.1

            7.4

            −1.3

            No

            P004

            11.1

            10.3

            9.2

            −1.9

            No

            P005

            9.4

            8.7

            7.9

            −1.5

            No

            P006

            10.8

            10.0

            9.1

            −1.7

            No

            P007

            8.3

            7.6

            7.0

            −1.3

            No

            P008

            9.9

            9.2

            8.3

            −1.6

            No

            P009

            8.9

            8.3

            7.5

            −1.4

            No

            P010

            11.4

            10.7

            9.6

            −1.8

            No

            P011

            8.5

            7.9

            7.1

            −1.4

            No

            P012

            10.6

            9.8

            8.9

            −1.7

            No

            P013

            9.7

            9.0

            8.2

            −1.5

            No

            P014

            10.9

            10.2

            9.3

            −1.6

            No

            P015

            8.2

            7.5

            6.9

            −1.3

            Yes

            P016

            9.3

            8.6

            7.8

            −1.5

            No

            P017

            10.1

            9.4

            8.5

            −1.6

            No

            P018

            11.7

            10.9

            9.8

            −1.9

            No

            P019

            7.8

            7.2

            6.7

            −1.1

            Yes

            P020

            9.6

            8.9

            8.0

            −1.6

            No

            Note. HbA1c values (%) were obtained from laboratory results integrated into the clinic EHR at Baseline (Week 1), Week 4, and Week 8. Change score reflects Week 8 HbA1c minus Baseline HbA1c. Target achievement was defined as HbA1c < 7% per ADA Standards of Care. HbA1c = hemoglobin A1c; ADA = American Diabetes Association.

            Table 3

            Follow-Up Adherence and Visit Completion Data (N = 20)

            Participant ID

            Scheduled Visits (n = 6)

            Completed Visits (n)

            Missed Visits (n)

            Telehealth Visits Used

            Completion Rate (%)

            P001

            6

            6

            0

            1

            100

            P002

            6

            5

            1

            0

            83

            P003

            6

            6

            0

            2

            100

            P004

            6

            4

            2

            1

            67

            P005

            6

            6

            0

            0

            100

            P006

            6

            5

            1

            2

            83

            P007

            6

            6

            0

            1

            100

            P008

            6

            6

            0

            0

            100

            P009

            6

            5

            1

            1

            83

            P010

            6

            4

            2

            2

            67

            P011

            6

            6

            0

            0

            100

            P012

            6

            6

            0

            1

            100

            P013

            6

            5

            1

            0

            83

            P014

            6

            6

            0

            2

            100

            P015

            6

            6

            0

            0

            100

            P016

            6

            5

            1

            1

            83

            P017

            6

            6

            0

            1

            100

            P018

            6

            4

            2

            2

            67

            P019

            6

            6

            0

            0

            100

            P020

            6

            5

            1

            1

            83

            Note. Biweekly follow-up visits were scheduled over the 8-week implementation period (6 visits per patient). Telehealth visits were offered to patients with mobility or transportation barriers. Completion rate = (completed visits / 6) x 100.

            Table 4

            Nursing Staff Competency Assessment Results (N = 8)

            Staff ID

            Role

            Pre-Training Score (/100)

            Post-Training Score (/100)

            Score Change

            Threshold Met (>=80%)

            Checklist Completion (%)

            S001

            Nurse Practitioner

            62

            88

            +26

            Yes

            95

            S002

            Nurse Practitioner

            58

            84

            +26

            Yes

            92

            S003

            Nurse Practitioner

            65

            91

            +26

            Yes

            98

            S004

            Medical Assistant

            50

            78

            +28

            No

            85

            S005

            Medical Assistant

            55

            83

            +28

            Yes

            88

            S006

            Care Coordinator

            60

            86

            +26

            Yes

            94

            S007

            Health Educator

            70

            93

            +23

            Yes

            97

            S008

            Medical Assistant

            52

            80

            +28

            Yes

            89

            Note. Pre-training and post-training scores were obtained from the validated diabetes management competency assessment instrument administered at Week 1 and Week 8. The pre-defined competency success criterion was a score >= 80%. Checklist completion reflects the percentage of randomly audited patient visits with complete fidelity documentation.

            Table 5

            Self-Management Behavior Checklist — Week 8 (N = 20)

            Participant ID

            Blood Glucose Monitoring (Daily)

            Medication Adherence (Self-Report)

            Diet/Nutrition Log Completed

            Physical Activity Goal Met

            Engagement Score (/10)

            P001

            Yes

            Yes

            Yes

            Partial

            8

            P002

            Partial

            Yes

            No

            No

            5

            P003

            Yes

            Yes

            Yes

            Yes

            9

            P004

            No

            Partial

            No

            No

            4

            P005

            Yes

            Yes

            Yes

            Yes

            10

            P006

            Partial

            Yes

            Yes

            Partial

            7

            P007

            Yes

            Yes

            Yes

            Yes

            10

            P008

            Yes

            Yes

            Partial

            Yes

            8

            P009

            Yes

            Yes

            Yes

            Partial

            8

            P010

            No

            Partial

            No

            No

            3

            P011

            Yes

            Yes

            Yes

            Yes

            9

            P012

            Yes

            Yes

            Yes

            Partial

            8

            P013

            Partial

            Yes

            Partial

            Yes

            7

            P014

            Partial

            Yes

            Yes

            Partial

            7

            P015

            Yes

            Yes

            Yes

            Yes

            10

            P016

            Yes

            Yes

            Yes

            Yes

            9

            P017

            Partial

            Partial

            Yes

            No

            6

            P018

            No

            Partial

            No

            No

            3

            P019

            Yes

            Yes

            Yes

            Yes

            10

            P020

            Yes

            Yes

            Yes

            Partial

            8

            Note. Self-management behaviors were self-reported by patients at the Week 8 follow-up visit using the standardized self-management checklist. Engagement score was assigned by nursing staff on a 10-point scale based on patient participation, responsiveness, and adherence across the 8 weeks. Partial = behavior was sometimes but not consistently performed.

            Table 6

            Summary Statistics: Project Implementation Outcomes

            Metric

            Value

            Total patients enrolled (N)

            20

            Mean baseline HbA1c (%)

            9.95

            Mean Week 8 HbA1c (%)

            8.22

            Mean HbA1c reduction

            −1.52%

            Patients achieving HbA1c < 7% at Week 8, n (%)

            2 (10%)

            Overall follow-up completion rate

            89.2%

            Staff achieving >= 80% competency threshold, n (%)

            7 (87.5%)

            Mean staff pre-training score

            59.0

            Mean staff post-training score

            85.4

            Patients reporting full medication adherence, n (%)

            14 (70%)

            Patients with complete blood glucose monitoring, n (%)

            13 (65%)

            Note. Summary statistics were calculated from EHR data, competency assessments, and patient self-management checklists collected across the 8-week implementation period. HbA1c = hemoglobin A1c; T2DM = type 2 diabetes mellitus.

            Best Capella Professors To Choose From For NURS-FPX9030 Class

            ×

              Please enter correct phone number and email address to receive OTP on your phone & email.

              Privacy PolicySMS Terms And Conditions

              • Nicole Aclin, DNP, RN, CNE.
              • Adriane Stasurak, DNP, RN, ANP-BC.

              (FAQs) related to 
              NURS FPX 9030 Assessment 2

              ×

                Please enter correct phone number and email address to receive OTP on your phone & email.

                Privacy PolicySMS Terms And Conditions

                Question 1: What is NURS FPX 9030 Assessment 2 about?

                Answer 1: It analyzes QI project data evaluating ADA protocol’s impact on diabetic patients’ glycemic outcomes.

                Question 2: Where can I get expert help with NURS FPX 9030 Assessment 2?

                Answer 2: Get expert guidance for NURS FPX 9030 Assessment 2 by visiting TutorsAcademy.co.

                Do you need a tutor to help with this paper for you within 24 hours


                  Privacy PolicySMS Terms And Conditions

                  ← Previous Assessment: NURS FPX 9030 Assessment 1 | Next Assessment: NURS FPX 9030 Assessment 3 

                  Please Fill The Following to Resume Reading

                    Please enter correct phone number and email address to receive OTP on your phone & email.

                    Privacy PolicySMS Terms And Conditions

                    Verification is required to prevent automated bots.
                    Please Fill The Following to Resume Reading

                      Please enter correct phone number and email address to receive OTP on your phone & email.

                      Privacy PolicySMS Terms And Conditions

                      Verification is required to prevent automated bots.
                      Scroll to Top